av/bright-minds-biosciences--big.svg

NASDAQ:DRUG

Bright Minds Biosciences Inc.

  • Stock

USD

Last Close

1.45

23/07 17:48

Market Cap

6.12M

Beta: 1.25

PE Ratio

−1.30

PFCF: −1.69

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
asset turnover
cash per share
0.06
-
0.69
1,006.30%
11.01
1,493.31%
0.94
91.45%
1.84
95.17%
company equity multiplier
1.29
-
1.21
6.33%
1.03
14.42%
1.15
11.00%
1.04
9.07%
days of inventory outstanding
days of payables outstanding
918.45
-
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.00
-
1.02
2.35%
0.99
3.50%
1.02
2.78%
1.00
1.87%
effective tax rate
0.00
-
-0.01
486.36%
0.02
235.07%
-0.01
195.09%
0.00
112.93%
enterprise value multiple
-694.48
-
-103.74
85.06%
-7.01
93.25%
-6.35
9.44%
-0.18
97.15%
fixed asset turnover
free cash flow per share
-0.03
-
-0.25
659.46%
-4.08
1,537.01%
-1.10
73.03%
-1.89
71.67%
gross profit margin
interest coverage
-66.17
-
-374.71
466.25%
inventory turnover
long term debt to capitalization
0.01
-
net income per ebt
1
-
1.01
1.16%
0.98
2.69%
1.01
3.10%
1
1.47%
net profit margin
operating cash flow per share
-0.03
-
-0.25
659.46%
-4.08
1,537.01%
-1.10
73.03%
-1.89
71.67%
operating profit margin
payables turnover
0.40
-
pretax profit margin
price fair value
430.21
-
67.86
84.23%
4.18
93.84%
9.96
138.17%
1.21
87.83%
receivables turnover
return on assets
-0.48
-
-0.55
15.00%
-0.42
23.03%
-1.26
195.72%
-1.07
14.71%
return on capital employed
-0.62
-
-0.64
4.04%
-0.45
29.86%
-1.39
207.66%
-1.12
19.24%
return on equity
-0.62
-
-0.67
7.72%
-0.44
34.13%
-1.44
228.24%
-1.12
22.44%
total debt to capitalization
0.01
-
0.01
15.83%

All numbers in USD (except ratios and percentages)